SGIOY
Price
$8.62
Change
+$0.03 (+0.35%)
Updated
Aug 27 closing price
Capitalization
14.7B
60 days until earnings call
TAK
Price
$14.95
Change
+$0.09 (+0.61%)
Updated
Aug 28, 10:40 AM (EDT)
Capitalization
46.9B
63 days until earnings call
Interact to see
Advertisement

SGIOY vs TAK

Header iconSGIOY vs TAK Comparison
Open Charts SGIOY vs TAKBanner chart's image
Shionogi & Co
Price$8.62
Change+$0.03 (+0.35%)
Volume$40.05K
Capitalization14.7B
Takeda Pharmaceutical
Price$14.95
Change+$0.09 (+0.61%)
Volume$800
Capitalization46.9B
SGIOY vs TAK Comparison Chart in %
Loading...
SGIOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SGIOY vs. TAK commentary
Aug 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SGIOY is a Hold and TAK is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 28, 2025
Stock price -- (SGIOY: $8.62 vs. TAK: $14.86)
Brand notoriety: SGIOY and TAK are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: SGIOY: 54% vs. TAK: 50%
Market capitalization -- SGIOY: $14.7B vs. TAK: $46.9B
SGIOY [@Pharmaceuticals: Generic] is valued at $14.7B. TAK’s [@Pharmaceuticals: Generic] market capitalization is $46.9B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.86B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SGIOY’s FA Score shows that 2 FA rating(s) are green whileTAK’s FA Score has 2 green FA rating(s).

  • SGIOY’s FA Score: 2 green, 3 red.
  • TAK’s FA Score: 2 green, 3 red.
According to our system of comparison, SGIOY is a better buy in the long-term than TAK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SGIOY’s TA Score shows that 3 TA indicator(s) are bullish while TAK’s TA Score has 5 bullish TA indicator(s).

  • SGIOY’s TA Score: 3 bullish, 6 bearish.
  • TAK’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, TAK is a better buy in the short-term than SGIOY.

Price Growth

SGIOY (@Pharmaceuticals: Generic) experienced а -3.78% price change this week, while TAK (@Pharmaceuticals: Generic) price change was -4.01% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +2.19%. For the same industry, the average monthly price growth was +10.32%, and the average quarterly price growth was +79.93%.

Reported Earning Dates

SGIOY is expected to report earnings on Oct 27, 2025.

TAK is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+2.19% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TAK($46.9B) has a higher market cap than SGIOY($14.7B). TAK has higher P/E ratio than SGIOY: TAK (51.38) vs SGIOY (12.73). SGIOY YTD gains are higher at: 23.852 vs. TAK (12.236). TAK has higher annual earnings (EBITDA): 1.13T vs. SGIOY (206B). SGIOY has more cash in the bank: 576B vs. TAK (419B). SGIOY has less debt than TAK: SGIOY (11.7B) vs TAK (4.51T). TAK has higher revenues than SGIOY: TAK (4.48T) vs SGIOY (419B).
SGIOYTAKSGIOY / TAK
Capitalization14.7B46.9B31%
EBITDA206B1.13T18%
Gain YTD23.85212.236195%
P/E Ratio12.7351.3825%
Revenue419B4.48T9%
Total Cash576B419B137%
Total Debt11.7B4.51T0%
FUNDAMENTALS RATINGS
SGIOY vs TAK: Fundamental Ratings
SGIOY
TAK
OUTLOOK RATING
1..100
2223
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
6
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
288
PRICE GROWTH RATING
1..100
5254
P/E GROWTH RATING
1..100
4833
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TAK's Valuation (6) in the Pharmaceuticals Major industry is in the same range as SGIOY (20) in the null industry. This means that TAK’s stock grew similarly to SGIOY’s over the last 12 months.

TAK's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as SGIOY (100) in the null industry. This means that TAK’s stock grew similarly to SGIOY’s over the last 12 months.

SGIOY's SMR Rating (2) in the null industry is significantly better than the same rating for TAK (88) in the Pharmaceuticals Major industry. This means that SGIOY’s stock grew significantly faster than TAK’s over the last 12 months.

SGIOY's Price Growth Rating (52) in the null industry is in the same range as TAK (54) in the Pharmaceuticals Major industry. This means that SGIOY’s stock grew similarly to TAK’s over the last 12 months.

TAK's P/E Growth Rating (33) in the Pharmaceuticals Major industry is in the same range as SGIOY (48) in the null industry. This means that TAK’s stock grew similarly to SGIOY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SGIOYTAK
RSI
ODDS (%)
Bearish Trend 3 days ago
63%
Bearish Trend 3 days ago
46%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
62%
Bearish Trend 3 days ago
58%
Momentum
ODDS (%)
Bearish Trend 3 days ago
63%
Bullish Trend 3 days ago
39%
MACD
ODDS (%)
Bearish Trend 3 days ago
66%
Bullish Trend 3 days ago
43%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
61%
Bearish Trend 3 days ago
50%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
64%
Bullish Trend 3 days ago
36%
Advances
ODDS (%)
Bullish Trend 9 days ago
65%
Bullish Trend 9 days ago
41%
Declines
ODDS (%)
Bearish Trend 3 days ago
59%
Bearish Trend 3 days ago
45%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
58%
Bearish Trend 3 days ago
53%
Aroon
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
47%
View a ticker or compare two or three
Interact to see
Advertisement
SGIOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GLIN44.660.12
+0.27%
VanEck India Growth Ldrs ETF
KONG30.340.07
+0.23%
Formidable Fortress ETF
USDX25.690.03
+0.12%
SGI Enhanced Core ETF
BSCR19.700.02
+0.10%
Invesco BulletShares 2027 Corp Bd ETF
SJCP25.23N/A
N/A
SanJac Alpha Core Plus Bond ETF

SGIOY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SGIOY has been loosely correlated with TAK. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if SGIOY jumps, then TAK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGIOY
1D Price
Change %
SGIOY100%
+0.35%
TAK - SGIOY
40%
Loosely correlated
-0.13%
ESAIY - SGIOY
36%
Loosely correlated
-0.64%
KMDA - SGIOY
27%
Poorly correlated
+1.13%
SCYX - SGIOY
23%
Poorly correlated
+1.87%
SUPN - SGIOY
22%
Poorly correlated
+1.69%
More